and Biological Engineering, and the American Academy of Arts and Sciences. He served as a member of the Space Studies Board of the U.S. National Research Council (NRC), which advises the National Academy of Sciences, National Academy of Engineering, and National Institute of Medicine, and he chaired its Committee on Space Biology and Medicine. He has been an external reviewer of multiple NRC reports, including “Plan for the International Space Station,” “Future Biotechnology Research on the International Space Station,” "Assessment of Directions in Microgravity and Physical Sciences Research at NASA", and “The Astrophysical Context of Life.” Ingber also has served as a consultant to numerous companies in the pharmaceutical, biotechnology, and cosmetics industries, including Merck, Roche, Astrazeneca, Biogen, Chanel, and L’Oreal, among others. He currently chairs the Scientific Advisory Boards of Emulate, Inc. and Boa Biomedical, Inc. He is an advisory board member for Integrative Biology. Awards Ingber has received numerous awards and distinctions, including: 2021: Elected a member of the National Academy of Engineering for interdisciplinary contributions to mechanobiology and microsystems engineering, and leadership in biologically inspired engineering. 2018: Named to the Highly Cited Researchers List 2006–2016 by Clarivate Analytics. 2017: Founder's Award from the Biophysical Society. 2016: Elected to the American Academy of Arts and Sciences, and received the Shu Chien Award from the Biomedical Engineering Society, Pioneer Award from the University of Pittsburgh, and Max Tishler Lecture Award from Tufts University. 2015: Elected to the National Academy of Inventors, and won Product Design and Best Design of the Year Awards from London Design Museum for Organs-on-Chips, named Leading Global Thinker of 2015 by Foreign Policy Magazine. 2014: Delivered the Graeme Clark Oration in Melbourne, Australia to an audience of over 1,400. 2013: Received the NC3Rs 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), and was named an honorary member of the Society of Toxicology for his work on Organs-on-Chips. 2012: Elected to the National Institute of Medicine (formerly Institute of Medicine) of the U.S. National Academies, one of the highest honors in the field of medicine in the United States, and won the World Technology Award in the biotechnology category. 2011: Inducted into the American Institute for Medical and Biological Engineering's College of Fellows and received the Holst Medal. 2010: Received the Lifetime Achievement Award from the Society for In Vitro Biology and the Rous-Whipple Award from